Cargando…

Calcium inhibitor inhibits high glucose-induced hypertrophy of H9C2 cells

The aim of the present study was to explore whether the hypertrophy of H9C2 cardiomyocytes was induced by high glucose, to investigate whether the calcium channel inhibitor (Norvasc) could inhibit this process and to clarify the possible signaling pathways. The morphology of H9C2 cells was observed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaohong, Ruan, Luoyang, Tian, Xiaohua, Pan, Fengjuan, Yang, Cailan, Liu, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411357/ https://www.ncbi.nlm.nih.gov/pubmed/32705176 http://dx.doi.org/10.3892/mmr.2020.11275

Ejemplares similares

Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells
por: Lee, Hyunjung, et al.
Publicado: (2016)

Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats
por: Tang, Liqun, et al.
Publicado: (2020)

Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression
por: Abdulrahman, Nabeel, et al.
Publicado: (2022)

The Melanocortin MC5R as a New Target for Treatment of High Glucose-Induced Hypertrophy of the Cardiac H9c2 Cells
por: Trotta, Maria Consiglia, et al.
Publicado: (2018)

Resveratrol Inhibits High Glucose-Induced H9c2 Cardiomyocyte Hypertrophy and Damage via RAGE-Dependent Inhibition of the NF-κB and TGF-β1/Smad3 Pathways
por: Zhu, Yanzhou, et al.
Publicado: (2022)

Suppression of calcium-sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy
por: LIU, LEI, et al.
Publicado: (2016)

Quercetin Inhibits Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats and Inhibits Angiotensin II-Induced H9C2 Cells Hypertrophy by Enhancing PPAR-γ Expression and Suppressing AP-1 Activity
por: Yan, Lei, et al.
Publicado: (2013)

TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells
por: Cheng, Kai-Chun, et al.
Publicado: (2019)

Glucose-6-phosphate dehydrogenase is critical for suppression of cardiac hypertrophy by H(2)S
por: Chhabra, Aastha, et al.
Publicado: (2018)

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway
por: Wang, Min, et al.
Publicado: (2020)

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway
por: Wang, Min, et al.
Publicado: (2022)

EGCG Blocked Phenylephrin-Induced Hypertrophy in H9C2 Cardiomyocytes, by Activating AMPK-Dependent Pathway
por: Cai, Yi, et al.
Publicado: (2015)

Protective Effects of Nanoceria against Mitochondrial Dysfunction and Angiotensin II-Induced Hypertrophy in H9c2 Cardiomyoblasts
por: Gul, Rukhsana, et al.
Publicado: (2023)

Astragalus polysaccharides inhibit oxidation in high glucose-challenged or SOD2-silenced H9C2 cells
por: Chen, Wei, et al.
Publicado: (2018)

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2011)

Icariin attenuates angiotensin II-induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species-dependent JNK and p38 pathways
por: ZHOU, HENG, et al.
Publicado: (2014)

MicroRNA-194 inhibits isoproterenol-induced chronic cardiac hypertrophy via targeting CnA/NFATc2 signaling in H9c2 cells
por: Wang, Jian, et al.
Publicado: (2022)

Lotus Bee Pollen Extract Inhibits Isoproterenol-Induced Hypertrophy via JAK2/STAT3 Signaling Pathway in Rat H9c2 Cells
por: Han, Shuo, et al.
Publicado: (2022)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes
por: Hwang, Jung Seok, et al.
Publicado: (2021)

Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy
por: Siti, Hawa Nordin, et al.
Publicado: (2021)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity
por: Li, Jie, et al.
Publicado: (2017)

A perinuclear calcium compartment regulates cardiac myocyte hypertrophy
por: Turcotte, Moriah Gildart, et al.
Publicado: (2022)

C‐C Motif Chemokine Receptor 9 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction
por: Xu, Zhengxi, et al.
Publicado: (2016)

High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy
por: Wu, Qing-Rui, et al.
Publicado: (2021)

Protective Effect of Boerhaavia diffusa L. against Mitochondrial Dysfunction in Angiotensin II Induced Hypertrophy in H9c2 Cardiomyoblast Cells
por: Prathapan, Ayyappan, et al.
Publicado: (2014)

Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia
por: Li, Hong, et al.
Publicado: (2017)

Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells
por: Yang, Dafeng, et al.
Publicado: (2017)

Metoprolol alleviates arginine vasopressin-induced cardiomyocyte hypertrophy by upregulating the AKT1–SERCA2 cascade in H9C2 cells
por: Zhao, Jieqiong, et al.
Publicado: (2020)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Folic Acid Alleviates High Glucose and Fat-Induced Pyroptosis via Inhibition of the Hippo Signal Pathway on H9C2 Cells
por: Hong, Lei, et al.
Publicado: (2021)

The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors
por: Sorriento, Daniela, et al.
Publicado: (2018)

Neuronal Calcium Sensor Synaptotagmin-9 Is Not Involved in the Regulation of Glucose Homeostasis or Insulin Secretion
por: Gustavsson, Natalia, et al.
Publicado: (2010)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-β2
por: Hiromura, Munenori, et al.
Publicado: (2022)

RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx
por: Xue, Honghong, et al.
Publicado: (2022)

The β(2)-Subunit of Voltage-Gated Calcium Channels Regulates Cardiomyocyte Hypertrophy
por: Pickel, Simone, et al.
Publicado: (2021)

Function of BRD4 in the pathogenesis of high glucose-induced cardiac hypertrophy
por: Wang, Qian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3rsbinuip4riefs25791jdfal8